Limaye, Dnyanesh
[VerfasserIn];
Kale, M.
[VerfasserIn];
Chitre, N.
[VerfasserIn];
Deshapande, D.
[VerfasserIn];
Desai, R.
[VerfasserIn];
Limaye, Vaidehi
[VerfasserIn];
Fortwengel, Gerhard
[VerfasserIn]
Cost-effectiveness Study of Antihypertensive Drugs in Mumbai, India
Beschreibung:
Hypertension is a serious global public health problem. It accounts for 10% of all deaths in India and is the leading noncommunicable disease.1 Recent studies have shown that the prevalence of hypertension is 25% in urban and 10% in rural people in India.2 It exerts a substantial public health burden on cardiovascular health status and health care systems in India.3 Antihypertensive treatment effectively reduces hypertension-related morbidity and mortality.1 The cost of medications has always been a barrier to effective treatment.